Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
about
The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studiesPopulation-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosisEvolution of the blood-brain barrier in newly forming multiple sclerosis lesionsCorrelations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelinesBiochemical changes within a multiple sclerosis plaque in vivoHigh dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effectSeizures due to multiple sclerosis: seven patients with MRI correlationsManagement of acute exacerbations in multiple sclerosis.Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with primary progressive multiple sclerosisCerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability.Towards quantitative measurements of relaxation times and other parameters in the brain.Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.Cognitive impairment in multiple sclerosis: clinical, radiologic and pathologic insights.The pathological evolution of multiple sclerosis.Blood-brain barrier disruption in CCL2 transgenic mice during pertussis toxin-induced brain inflammation.Benign course in multiple sclerosis: a review.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRIInitial investigation of the blood-brain barrier in MS lesions at 7 tesla.Magnetic resonance in monitoring the treatment of multiple sclerosis.Magnetic resonance imaging of multiple sclerosis lesions. Measuring outcome in treatment trials.Magnetic resonance in monitoring the natural history of multiple sclerosis and the effects of treatment.Contrast-enhanced MR imaging in the evaluation of treatment response and prediction of outcome in multiple sclerosis.Immune-mediated oligodendrocyte injury.Plasmapheresis in acute multiple sclerosis: rationale and results.Nuclear imaging of neuroinflammation: a comprehensive review of [11C]PK11195 challengers.Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.MRI evaluation of pathologies affecting the corpus callosum: A pictorial essay.Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis.Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.Bolus-tracking MRI with a simultaneous T1- and T2*-measurement.Triple dose of gadolinium-DTPA and delayed MRI in patients with benign multiple sclerosis.Epilepsy in patients with multiple sclerosis: radiological-clinical correlations.Serial cranial and spinal cord magnetic resonance imaging in multiple sclerosis.Early dynamic SPECT imaging in acute viral encephalitis.Triple-dose versus single-dose gadoteridol in multiple sclerosis patients.Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.Magnetic resonance imaging of blood-spinal cord barrier disruption in mice with experimental autoimmune encephalomyelitis.Focal experimental autoimmune encephalomyelitis in the Lewis rat induced by immunization with myelin oligodendrocyte glycoprotein and intraspinal injection of vascular endothelial growth factor.Activated non-neural specific T cells open the blood-brain barrier to circulating antibodies.
P2860
Q24605294-55071029-178A-491B-8839-85C682ADB751Q24632212-809480C0-E7F8-44D0-9FE4-331F8DD57694Q30502812-C5F0B723-D92C-4C89-B85C-81D8502CA710Q32091527-6FB06CA4-0966-41CD-B395-D8D612DEA361Q33437936-DECF41DF-9AD2-459C-B051-442AC9AA1D2AQ33590069-3E7DC5BE-D0DA-45E0-A93E-64CE1DC675F8Q33590797-544937F7-8E70-4806-858B-977145622CE4Q33592300-C45660F6-F45D-4E40-9B39-899D7F9DA270Q33670934-B952FBF4-303A-49DB-84B8-FCE902D24E24Q33734744-45CB788F-5E0F-4E4E-80FB-F67C896CA624Q33912628-E7D9DC9F-DD11-47EE-8D26-328B04B7B718Q34272317-7D865161-8247-42EE-98A3-064BCF7523E7Q35402503-0FF1F1F8-AACE-4EF1-8818-8E28415C5CDEQ35529255-71EE1AC8-86B5-4619-A38E-854CD20397C7Q35850662-E0DFEA27-987B-4051-8184-7DC1F8EFD340Q36173387-F355FE27-4467-4418-821A-D43829B8CA51Q36468278-3B92CF21-FB18-4293-B0D6-529464BFB4DEQ36501363-12D7147A-E727-4B0A-A6AD-C137B0678DC6Q36554151-7E890331-1A2B-4C79-8C80-72A207EDB5A2Q36732803-0C74374B-7F7A-4301-9074-C31C7A83B6C8Q36814514-AEA89418-F5D6-4067-BE0E-EEA8AE8B663CQ36839900-32418483-B84C-4FF3-B377-04CC451217C2Q36847324-643589B4-E4DA-4B0C-A22F-E251D241A10CQ36951484-CF924422-ADB0-4E53-96B5-E2EE983105CAQ37046264-460F1E41-C52F-4B59-8120-97593207CEA0Q37283568-C128EA2F-D9E2-4552-B9AE-0A45F0B657B9Q37385073-6890E646-41C6-4E4A-8711-3403F42CA8EBQ37599192-96153D96-4B1C-4983-9383-48627C2D82C6Q37866587-1D769AB1-7F91-4840-A672-8B4791FD6199Q38096874-CFEB3DE1-01EF-41FD-A301-966A7785596BQ39827530-7E970A41-8D9B-476E-82D3-64DBF3D6D46BQ41353226-F4F3DCBB-8DBC-4377-BF44-64EBE5E7865EQ43751922-86F883E8-A9D6-4D82-A590-35A67913D624Q44405590-09816E9A-5AAE-4AD4-96CA-4EF8EC48FB86Q46982464-7A2AB3BE-639D-4297-AC5A-6DCCDEAAE409Q48092361-32F6B93B-C26D-46B7-82AD-8B1016B33AB0Q48093875-47FF2330-187E-4460-A10E-D40DC16BEAE1Q48094861-2FF5E482-91BC-4396-9EF3-433F276A6F60Q48120862-4C55559C-775F-41D0-B6D3-6E8185896BCAQ48174524-7B929716-60B1-420A-9320-37F2A223939B
P2860
Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@en
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@nl
type
label
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@en
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@nl
prefLabel
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@en
Heterogeneity of blood-brain b ...... h gadolinium-DTPA enhancement.
@nl
P2093
P356
P1433
P1476
Heterogeneity of blood-brain b ...... th gadolinium-DTPA enhancement
@en
P2093
A J Thompson
B E Kendall
D G MacManus
D P Kingsley
E P du Boulay
I F Moseley
W I McDonald
P304
P356
10.1212/WNL.40.2.229
P407
P577
1990-02-01T00:00:00Z